Analyst consensus as of 7 May 2019 for FY 2019.
From a survey of nine analysts:
|
|
Range (£m) |
Average (mean, £m) |
|
Sales |
943 - 970 |
953 |
|
EBITDA (pre-IFRS16) |
119 – 125 |
121 |
931.1m
revenue in 2018
7,700+
dedicated clinicians and clinical support staff
96%
patients ‘Likely’ or ‘Extremely Likely’ to recommend Paton Medicalgroup